Evoke Pharma Inc (EVOK) - News Archive

Showing 3 of 3 results.

Evoke Pharmas Strategic Moves: Pioneering Gastroparesis Solutions Amid Market Transitions and Shareholder Enhancements

In the ever-evolving landscape of pharmaceutical innovation, Evoke Pharma, Inc. (NASDAQ: EVOK) is carving out a significant niche as a leading provider of treatments for gastrointestinal (GI) disorders, particularly in...

Dec 19, 2024 • Major Pharmaceutical Preparations Industry Management Announcement EVOK

Evoke Pharma Initiates 1-for-12 Reverse Stock Split to Enhance Shareholder Value

Date: August 1, 2024SOLANA BEACH, Calif. - Evoke Pharma, Inc. (NASDAQ: EVOK), a pioneering specialty pharmaceutical company, announced today that its board of directors has approved a 1-for-12 reverse stock split of the...

Jul 30, 2024 • Major Pharmaceutical Preparations Industry Stock Market Announcement EVOK

Evoke Pharma: Seizing Opportunities to Revolutionize GI Therapeutics with Recent Underwritten Public Offering

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 MillionEvoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company specializing in gastrointestinal (GI) disease treatments, has rece...

Feb 9, 2024 • Major Pharmaceutical Preparations Industry Management Announcement financings